Work

PEGylated human IL-10 (AM0010) monotherapy in refractory metastatic colorectal cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.3571

Authors: Jeffrey R. Infante, Kyriakos P. Papadopoulos, Aung Naing, Karen A. Autio, Patrick Alexander Ott, Deborah Jean Lee Wong, Johanna C. Bendell, Todd Michael Bauer, Shubham Pant, Peter Van Vlasselaer, Gail Linda Brown, Martin Oft

Institutions: Tennessee Oncology, South Texas Accelerated Research Therapeutics, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University of California, Los Angeles, University of Oklahoma Health Sciences Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2887575762

Cites:

Cited by:

Related to: 10